News
CMRA
0.0002
NaN%
--
Weekly Report: what happened at CMRA last week (0414-0418)?
Weekly Report · 04/21 11:30
Weekly Report: what happened at CMRA last week (0407-0411)?
Weekly Report · 04/14 11:19
Weekly Report: what happened at CMRA last week (0331-0404)?
Weekly Report · 04/07 11:18
Weekly Report: what happened at CMRA last week (0324-0328)?
Weekly Report · 03/31 11:31
Weekly Report: what happened at CMRA last week (0317-0321)?
Weekly Report · 03/24 11:18
Weekly Report: what happened at CMRA last week (0310-0314)?
Weekly Report · 03/17 11:29
Weekly Report: what happened at CMRA last week (0303-0307)?
Weekly Report · 03/10 11:31
Weekly Report: what happened at CMRA last week (0224-0228)?
Weekly Report · 03/03 11:30
Weekly Report: what happened at CMRA last week (0217-0221)?
Weekly Report · 02/24 11:29
Weekly Report: what happened at CMRA last week (0210-0214)?
Weekly Report · 02/17 11:27
Weekly Report: what happened at CMRA last week (0203-0207)?
Weekly Report · 02/10 11:21
Weekly Report: what happened at CMRA last week (0127-0131)?
Weekly Report · 02/03 11:25
Weekly Report: what happened at CMRA last week (0120-0124)?
Weekly Report · 01/27 11:29
Weekly Report: what happened at CMRA last week (0113-0117)?
Weekly Report · 01/20 11:19
Weekly Report: what happened at CMRA last week (0106-0110)?
Weekly Report · 01/13 11:20
Weekly Report: what happened at CMRA last week (1230-0103)?
Weekly Report · 01/06 11:29
Weekly Report: what happened at CMRA last week (1223-1227)?
Weekly Report · 12/30/2024 11:23
Weekly Report: what happened at CMRA last week (1216-1220)?
Weekly Report · 12/23/2024 11:29
Weekly Report: what happened at CMRA last week (1209-1213)?
Weekly Report · 12/16/2024 11:30
Weekly Report: what happened at CMRA last week (1202-1206)?
Weekly Report · 12/09/2024 11:29
More
Webull provides a variety of real-time CMRA stock news. You can receive the latest news about Comera Life through multiple platforms. This information may help you make smarter investment decisions.
About CMRA
Comera Life Sciences Holdings, Inc. is a pre-clinical biotechnology company. The Company applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The Company is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.